Regulatory News

Issue of Shares and Total Voting Rights

RNS Number : 2908S
Darktrace PLC
12 November 2021

12 November 2021

Darktrace plc

("Darktrace" or the "Company")

Issue of Plan Shares under the Award Incentive Plan and Total Voting Rights

Darktrace announces that an application has been made to the Premium Listing Segment of the Official List of the Financial Conduct Authority and the London Stock Exchange for the listing and admission of 1,249,802 new ordinary shares.

The shares were issued pursuant to the exercise and vesting of Plan Shares granted under its Darktrace plc 2021 Award Incentive Plan to certain Canadian employees and members of the advisory council

The above shares will rank pari passu in all respects with the Company's existing ordinary shares of 1 penny each ("Ordinary Shares"). It is expected that admission will become effective on 16 November 2021.

As a result of the 1,249,802 ordinary shares issued, the total number of ordinary shares outstanding is 698,886,705. Each Ordinary Share carries the right to one vote. The Company does not hold any shares in treasury. Therefore, the total voting rights figure of 698,886,705 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


Luk Janssens - Head of Investor Relations   [email protected]




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.